These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7849387)

  • 21. A case of huge gastric varices successfully treated with endoscopic injection sclerotherapy with occlusion of both supplying and draining veins with balloons.
    Shiba M; Higuchi K; Nakamura K; Kuga T; Hamasaki N; Ando K; Fujiwara Y; Saeki Y; Arakawa T; Yamada R; Kuroki T
    Gastrointest Endosc; 2000 Jul; 52(1):104-7. PubMed ID: 10882975
    [No Abstract]   [Full Text] [Related]  

  • 22. [Esophageal carcinoma after the endoscopic sclerotherapy of varices].
    Macías Rodríguez MA; Soria de la Cruz MJ; Iglesias Arrabal M; Martín Herrera L
    Rev Esp Enferm Dig; 1992 Jul; 82(1):43-6. PubMed ID: 1520550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of pyogenic meningitis during the course of endoscopic variceal ligation therapy.
    Nagamine N; Kaneko Y; Kumakura Y; Ogawa Y; Ido K; Kimura K
    Gastrointest Endosc; 1999 Jan; 49(1):110-3. PubMed ID: 9869735
    [No Abstract]   [Full Text] [Related]  

  • 24. Streptococcus sanguinis meningitis following endoscopic ligation for oesophageal variceal haemorrhage.
    Liu YT; Lin CF; Lee YL
    J Med Microbiol; 2013 May; 62(Pt 5):794-796. PubMed ID: 23429697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial peritonitis following endoscopic variceal sclerotherapy.
    Barnett JL; Elta G
    Gastrointest Endosc; 1987 Aug; 33(4):316-7. PubMed ID: 3498663
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
    Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of portosystemic collaterals by SPECT imaging after endoscopic variceal sclerotherapy: usefulness for predicting recurrence.
    Azuma M; Kashiwagi T; Nagasawa M; Ito Y; Naito M; Ishibashi K; Katayama K
    J Nucl Med; 2000 Apr; 41(4):600-4. PubMed ID: 10768559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis.
    Strauss E; Ribeiro MF; Albano A; Honain NZ; Maffei RA; Caly WR
    J Gastroenterol Hepatol; 1999 Mar; 14(3):225-30. PubMed ID: 10197490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal varices treated with endoscopic injection sclerotherapy--a pathological study.
    Arakawa M; Kage M; Matsumoto S; Fukuda K; Nakashima T; Nagata K; Toyonaga A; Yamana H
    Kurume Med J; 1985; 32(2):131-9. PubMed ID: 3831594
    [No Abstract]   [Full Text] [Related]  

  • 30. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of bleeding esophago-gastric varices].
    Oho K; Toyonaga A
    Nihon Rinsho; 1998 Sep; 56(9):2325-30. PubMed ID: 9780714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.
    Sheikh RA; Trudeau WL
    Gastrointest Endosc; 2000 Jul; 52(1):142-4. PubMed ID: 11012301
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of elective endoscopic sclerotherapy of hemorrhage from esophageal varices. 2-year follow-up].
    Cabriada J; Orive V; Alzate LF; Arenas JI
    Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):429-34. PubMed ID: 3265215
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices.
    Fry LC; Neumann H; Olano C; Malfertheiner P; Mönkemüller K
    Dig Dis; 2008; 26(4):300-3. PubMed ID: 19188718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [38 cases of sclerotherapy of esophageal varices].
    Sigiyama K; Li ZL
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):263-5, 317. PubMed ID: 3876916
    [No Abstract]   [Full Text] [Related]  

  • 36. Pleural effusions following endoscopic injection sclerotherapy for cirrhotic patients with esophageal varices.
    Kayama H; Inamori M; Togawa J; Shimamura T; Tokita Y; Umezawa T; Sakaguchi T; Naitoh M; Nagase H; Nakajima A; Saito T; Tominaga S; Ueno N; Tanaka K; Sekihara H
    Hepatogastroenterology; 2006; 53(69):376-80. PubMed ID: 16795976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
    Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
    Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endoscopic sclerotherapy of esophageal varices with 80% alcohol. Experience with 46 cases].
    Guzmán SJ; Vetencourt R; Suárez A; Pifano F
    G E N; 1989; 43(3):149-54. PubMed ID: 2535556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.